Literature DB >> 19826564

Cognitive impairment in Parkinson's disease without dementia: subtypes and influences of age.

Jae Woo Kim1, Sang Myung Cheon, Min Jeong Park, Seong Yeon Kim, Hee Young Jo.   

Abstract

BACKGROUND AND
PURPOSE: Cognitive impairments are common in Parkinson's disease (PD), although the severity of these impairments does not significantly impair the patient's daily activities. The aim of this study was to determine the frequency of mild cognitive impairment (MCI) of Parkinson's disease (PDMCI) and its subtypes in nondemented PD patients. We also evaluated the influence of age on the pattern of subtypes of PDMCI.
METHODS: A total of 141 consecutive, nondemented PD patients underwent a comprehensive neuropsychological assessment covering the five cognitive domains: attention, language, visuospatial, memory, and executive functions. PDMCI was defined as impaired performance in at least one of these five cognitive domains. The influence of age on the distribution of subtypes of PDMCI was assessed by comparing patients in two groups dichotomized according to their age at assessment (younger vs. older).
RESULTS: Fifty-seven (40.4%) of the nondemented PD patients had an impairment in at least one domain, and were therefore considered as having PDMCI. The age at assessment and age at disease onset were significantly higher in the PDMCI patients. The amnestic type of PDMCI was the most frequent, followed by the visuospatial, linguistic, executive, and attention types in that order. The frequency of PDMCI was higher for all subtypes in the older group; the domain that was influenced the most by age was executive function.
CONCLUSIONS: MCI was common in PD and the subtypes were diverse. Age was found to be an important risk factor for the development of PDMCI, particularly for the executive subtype. These results indicate that the concept of MCI should be introduced in PD.

Entities:  

Keywords:  Parkinson's disease; Parkinson's disease dementia; mild cognitive impairment

Year:  2009        PMID: 19826564      PMCID: PMC2760718          DOI: 10.3988/jcn.2009.5.3.133

Source DB:  PubMed          Journal:  J Clin Neurol        ISSN: 1738-6586            Impact factor:   3.077


  18 in total

1.  Normative data on the Korean version of the Boston Naming Test.

Authors:  H Kim; D L Na
Journal:  J Clin Exp Neuropsychol       Date:  1999-02       Impact factor: 2.475

2.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

3.  Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.

Authors:  Carmen Cristea Janvin; Jan Petter Larsen; Dag Aarsland; Kenneth Hugdahl
Journal:  Mov Disord       Date:  2006-09       Impact factor: 10.338

4.  Rivastigmine for dementia associated with Parkinson's disease.

Authors:  Murat Emre; Dag Aarsland; Alberto Albanese; E Jane Byrne; Günther Deuschl; Peter P De Deyn; Franck Durif; Jaime Kulisevsky; Teus van Laar; Andrew Lees; Werner Poewe; Alain Robillard; Mario M Rosa; Erik Wolters; Peter Quarg; Sibel Tekin; Roger Lane
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

5.  Cognitive profile of patients with newly diagnosed Parkinson disease.

Authors:  Dino Muslimovic; Bart Post; Johannes D Speelman; Ben Schmand
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

6.  A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease.

Authors:  T A Hughes; H F Ross; S Musa; S Bhattacherjee; R N Nathan; R H Mindham; E G Spokes
Journal:  Neurology       Date:  2000-04-25       Impact factor: 9.910

7.  Age of disease onset influences cognition in Parkinson's disease.

Authors:  H L Katzen; B E Levin; M L Llabre
Journal:  J Int Neuropsychol Soc       Date:  1998-05       Impact factor: 2.892

8.  Age-induced cognitive disturbances in Parkinson's disease.

Authors:  B Dubois; B Pillon; N Sternic; F Lhermitte; Y Agid
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

9.  A clinicopathologic study of 100 cases of Parkinson's disease.

Authors:  A J Hughes; S E Daniel; S Blankson; A J Lees
Journal:  Arch Neurol       Date:  1993-02

Review 10.  Clinical diagnostic criteria for dementia associated with Parkinson's disease.

Authors:  Murat Emre; Dag Aarsland; Richard Brown; David J Burn; Charles Duyckaerts; Yoshikino Mizuno; Gerald Anthony Broe; Jeffrey Cummings; Dennis W Dickson; Serge Gauthier; Jennifer Goldman; Christopher Goetz; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Ian McKeith; Warren Olanow; Werner Poewe; Niall Quinn; Christina Sampaio; Eduardo Tolosa; Bruno Dubois
Journal:  Mov Disord       Date:  2007-09-15       Impact factor: 10.338

View more
  6 in total

1.  Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.

Authors:  Jennifer G Goldman; Samantha Holden; Bryan Bernard; Bichun Ouyang; Christopher G Goetz; Glenn T Stebbins
Journal:  Mov Disord       Date:  2013-10-09       Impact factor: 10.338

Review 2.  Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's Disease.

Authors:  S DeVaughn; E M Müller-Oehring; B Markey; H M Brontë-Stewart; T Schulte
Journal:  Neuropsychol Rev       Date:  2015-11-17       Impact factor: 7.444

3.  Cognitive impairments in multiple system atrophy of the cerebellar type.

Authors:  Hyun J Hong; Sook Keun Song; Phil Hyu Lee; Young Ho Sohn; Ji E Lee
Journal:  J Mov Disord       Date:  2011-04-30

4.  Effects of age, stage of disease, and educational level on cognitive dysfunction in non-demented idiopathic Parkinsonism: A preliminary report.

Authors:  Saptarshi Adhikari; Jayanti Basu; Shyamal Kumar Das; Amar Kumar Misra
Journal:  Ind Psychiatry J       Date:  2012-01

5.  Relationship between Cognitive Performance and Motor Dysfunction in Patients with Parkinson's Disease: A Pilot Cross-Sectional Study.

Authors:  Valentina Varalta; Alessandro Picelli; Cristina Fonte; Stefania Amato; Camilla Melotti; Vanja Zatezalo; Leopold Saltuari; Nicola Smania
Journal:  Biomed Res Int       Date:  2015-03-31       Impact factor: 3.411

Review 6.  Quantitative EEG and Cognitive Decline in Parkinson's Disease.

Authors:  Vitalii V Cozac; Ute Gschwandtner; Florian Hatz; Martin Hardmeier; Stephan Rüegg; Peter Fuhr
Journal:  Parkinsons Dis       Date:  2016-04-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.